中文

News & Events

dMed in 3rd Annual China Biomed Innovation and Investment Conference
2018-11-21Return>>
The 3rd Annual China BioMed Innovation and Investment Conference, jointly sponsored by China Pharmaceutical Innovation and Research Development Association (PhIRDA) and other industry associations, was held between September 18th and 20th 2018 in Suzhou Industrial Park. Dr. Lingshi Tan, Chairman & CEO of dMed Biopharmaceutical Co., Ltd., introduced dMed, a next-generation CRO, during the Non-Listed Company Roadshow. Dr. Tan focused on the environment under which the company was founded, how dMed differentiates itself from other CROs, core members of the management team and both progress and prospects. Unlike countries with mature drug development process in place, the value of CROs in the VIC model is augmented in China. dMed carries the mission to provide high-quality and efficient services and to become the most trusted partner in clinical development. dMed creates world-class partnerships by recruiting the best talents with extensive global experience from leading international biopharma and service firms; Deploying cutting-edge technologies; And jointly developing innovative solutions for customers’ challenges.


Dr. Tan and Dr. Liemin Ding, CEO of Betta Pharmaceuticals, presided over the first and second half of the Global Clinical Data Release. Therein, the eight projects focused on disease areas that lacked effective treatments. Projects released this year received widespread attention because they were more innovative and with better clinical data outcomes, compared with previous years. Dr Tan also chaired the Enhancing Pharmaceutical R & D Capability Forum. Keynote speeches such as The Status Survey of Chinese Pharmaceutical R&D Outsourcing Service Industry and CRO’s Role and Responsibility in the Era of ICH Environment have great inspiration for outsourcing industry.


Highly regarded and internationally renowned, the innovation and investment conference provided a broad and high-level cooperation platform for domestic/foreign innovation projects, enterprises and investors, as well as opportunities for in-depth exchanges among industry leaders, experts, scholars and media.

298 Xiangke Road, 3/F, 301-305, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201210, China
Tel: +86 21 5090 0085 Fax: +86 21 6875 5515
沪ICP备16041651号-1 Copyright © 2016 dMed All Rights Reserved
沪公网安备 31011502005403号